Login to Your Account



AB Science's AD Program Gets $11M in Project Funds

By Cormac Sheridan
Staff Writer

Wednesday, July 24, 2013

AB Science SA received a €5.9 million (US$7.8 million) funding boost for its Phase III development program of masitinib in Alzheimer's disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription